Cart
sales@molnova.com
L(+)-Ornithine hydrochloride
CAS No. 3184-13-2
L(+)-Ornithine hydrochloride( —— )
Catalog No. M18420 CAS No. 3184-13-2
L-ornithine hydrochloride has an antifatigue effect by increasing the efficiency of energy consumption and promoting the excretion of ammonia. It is one of the key reactants in the urea cycle.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 28 | In Stock |
|
| 100MG | 39 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 60 | In Stock |
|
| 1G | 86 | In Stock |
|
Biological Information
-
Product NameL(+)-Ornithine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-ornithine hydrochloride has an antifatigue effect by increasing the efficiency of energy consumption and promoting the excretion of ammonia. It is one of the key reactants in the urea cycle.
-
DescriptionL-ornithine hydrochloride has an antifatigue effect by increasing the efficiency of energy consumption and promoting the excretion of ammonia. It is one of the key reactants in the urea cycle.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3184-13-2
-
Formula Weight168.62
-
Molecular FormulaC5H13ClN2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (296.52 mM)
-
SMILESC(CC(C(=O)O)N)CN.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
LEAP-2 (38 - 77) (Hu...
LEAP-2 (38 - 77) (Human)
-
Diphenylterazine
Diphenylterazine is a bioluminescence compound.Diphenylterazine alone yields very little background with excellent signal-to-background ratios. Furthermore, Diphenylterazine elicits minimal cell toxicity at millimolar concentrations. Diphenylterazine injections into untransfected BALB/c mice do not yield any background emission.
-
FKBP12 PROTAC RC32
FKBP12 PROTAC RC32 is a PROTAC-like degrader targeting FKBP12. It can degrade FKBP12 in organs after intraperitoneal administration.
